Hello Friends! Are you looking to invest in the stock market, or have you already invested? Would you like to know the predictions regarding the potential fluctuations in your shares? If so, you have landed on exactly the right page. On this page, you will find information regarding GPT Healthcare share News, Gpt healthcare share price 52 week high low, GPT Healthcare IPO share price, GPT Healthcare share price screener, GPT Healthcare share price target 2030, GPT Healthcare Share Price NSE, and much more. Furthermore, this page provides details on GPT Healthcare‘s share price targets 2026, 2027, 2028, 2029, 2030, 2040, and beyond.
GPT Healthcare Company Information
| Number of employees |
1,924 (2025) |
| Headquarters | India |
| Parent organization | GPT Sons Pvt. Ltd. |
GPT Healthcare Share Price Target Overview
- Current Price – 315.45
- Open – 140.70
- High – 144.09
- Low – 140.04
- Mkt cap – 1.17KCr
- P/E ratio – 28.89
- 52-wk high – 185.00
- 52-wk low – 115.00
- Dividend – 1.40%
- Qtrly div amt – 0.50
GPT Healthcare Share Price Chart
GPT Healthcare Share Price Target Tomorrow (Prediction)
| GPT Healthcare Share Price Target Years | GPT Healthcare Share Price Target |
| 2026 | ₹190 |
| 2027 | ₹210 |
| 2028 | ₹230 |
| 2029 | ₹250 |
| 2030 | ₹270 |
GPT Healthcare Share Price Target 2026
The target for GPT Healthcare’s share price in 2026 is projected to range between ₹180 and ₹190. As of mid of May 2026, GPT Healthcare’s share price stood at ₹315.45. Compared to the previous year, GPT Healthcare’s share price has witnessed an increase this year.
GPT Healthcare Share Price Target 2027
The target for GPT Healthcare’s share price in 2027 is projected to range between ₹200 and ₹210. On 20 May 2026, GPT Healthcare Share price NSE is 315.45 INR. Compared to last year, no significant difference has been observed in the share price of GPT Healthcare. The share price has increased by approximately 10-20 rupees.
GPT Healthcare Share Price Target 2030
The target for GPT Healthcare’s share price in 2030 is projected to range between ₹260 and ₹270. Over the past several years, the company has generated substantial profits, and investors, too, have earned handsome returns proportionate to their shareholdings. We remain optimistic that the company will continue to generate profits in the future, thereby ensuring continued returns for its investors.
Read Also:- Indo Count Industries Share Price Target Tomorrow From 2026 to 2030 – Current Chart, Market Overview
GPT Healthcare Shareholding Pattern
| Promoter | 65.57% |
| FII | 2.81% |
| DII | 2.15% |
| Retail & Others | 24.78% |
| Mutual Funds | 4.69% |
Income Statement Of GPT Healthcare
|
All values in INR
|
Mar 2025
|
Jun 2025
|
Sep 2025
|
Dec 2025
|
|---|---|---|---|---|
|
Revenue
|
1.01B
|
1.07B
|
1.19B
|
1.20B
|
|
Cost of goods sold
|
506.33M
|
410.93M
|
424.84M
|
449.63M
|
|
Cost of revenue
|
506.33M
|
410.93M
|
424.84M
|
449.63M
|
|
Research and development expenses
|
–
|
–
|
–
|
–
|
|
Total research and development expenses
|
–
|
–
|
–
|
–
|
|
Selling, general, and admin expenses
|
93.68M
|
–
|
–
|
–
|
|
Operating expense
|
349.56M
|
548.32M
|
605.30M
|
615.98M
|
|
Total operating expenses
|
855.89M
|
959.25M
|
1.03B
|
1.07B
|
|
Operating income
|
158.13M
|
111.83M
|
158.95M
|
135.98M
|
|
Other non operating income
|
-64.52M
|
15.63M
|
13.38M
|
14.22M
|
|
EBT including unusual items
|
163.69M
|
111.14M
|
150.69M
|
127.58M
|
|
EBT excluding unusual items
|
141.61M
|
111.14M
|
150.69M
|
127.58M
|
|
Income tax expense
|
34.79M
|
34.32M
|
44.65M
|
33.89M
|
|
Effective tax rate
|
21.25%
|
30.88%
|
29.63%
|
26.57%
|
|
Other operating expenses
|
207.10M
|
486.50M
|
536.82M
|
544.88M
|
|
Net income
|
128.90M
|
76.82M
|
106.04M
|
93.68M
|
|
Net profit margin
|
12.71%
|
7.17%
|
8.92%
|
7.80%
|
|
Earnings per share
|
–
|
–
|
–
|
–
|
|
Interest and investment income
|
48.75M
|
–
|
–
|
–
|
|
Interest expense
|
-752.00K
|
-16.33M
|
-21.64M
|
-22.62M
|
|
Net interest expenses
|
48.00M
|
-16.33M
|
-21.64M
|
-22.62M
|
|
Depreciation and amortization charges
|
48.77M
|
61.82M
|
68.48M
|
71.10M
|
|
EBITDA
|
190.06M
|
143.76M
|
224.10M
|
167.91M
|
|
Gain or loss from assets sale
|
–
|
–
|
–
|
–
|
Read Also:- Kotyark Industries Share Price Target Tomorrow From 2026 to 2030 – Market Overview, Prediction
Hi, I’m Ronak, a news writer covering the latest updates in automobiles, education, smartphones, and trending topics. I focus on delivering simple, clear, and timely news to keep readers informed about what’s happening around the world.